We are reviewing our formulary for all the iron formulations to determine which ones to keep and which ones to take off formulary.
Another key point of discussion coming from our provider is in favor of iron dextran given recent evidence. The push back anticipated is due to risk of reactions based on historical data.
I was hoping to get insight on institutional practices for preferencing one formulation over another, specifically iron dextran.
Thank you for the discussion!
